𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Degradation and drug release property of star poly(ϵ-caprolactone)s with dendritic cores

✍ Scribed by Zhi-Mei Miao; Si-Xue Cheng; Xian-Zheng Zhang; Qing-Rong Wang; Ren-Xi Zhuo


Book ID
102873962
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
590 KB
Volume
81B
Category
Article
ISSN
1552-4973

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A series of star poly(ϵ‐caprolactone)s (PCL) with dendritic cores, PAMAM‐PCLs, were synthesized through the ring‐opening polymerization of ϵ‐caprolactone (CL) initiated by poly(amidoamine) dendrimer (PAMAM‐OH). By controlling the feed ratio of the macroinitiator PAMAM‐OH to the monomer CL, the star polymers with different branch lengths and properties can be obtained. The successful incorporation of PCL sequences onto the PAMAM‐OH core was verified by FTIR, ^1^H NMR, and combined size‐exclusion chromatography and multiangle laser light scattering analysis. The in vitro degradation of PAMAM‐PCLs was investigated. The results show the hydrolytic degradation rate increases with increasing content of hydrophilic PAMAM‐OH core. While the enzymatic degradation rate is affected by two competitive factors, the catalytic effect of Pseudomonas cepacia lipase on the degradation of PCL branches and the hydrophilicity that depends on the polymer composition. Using the PAMAM‐PCLs with different molecular weights, the microsphere drug delivery systems with submicron sizes were fabricated using an “ultrasonic assisted precipitation method.” The in vitro drug release from these microspheres was investigated. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006


📜 SIMILAR VOLUMES


Study on the drug release property of ch
✍ Lan Yu; Hua Zhang; Si-Xue Cheng; Ren-Xi Zhuo; Hua Li 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract End‐functionalized poly/oligo(ε‐caprolactone)s were synthesized through the ring‐opening polymerization of ε‐caprolactone initiated by cholesterol with a hydroxyl group. Using the end‐functionalized poly/oligo(ε‐caprolactone)s with different molecular weights, the microsphere drug deliv